Adocia (France) Top Management

ADOC Stock  EUR 4.60  0.10  2.22%   
Adocia employs about 110 people. The company is managed by 22 executives with a total tenure of roughly 67 years, averaging almost 3.0 years of service per executive, having 5.0 employees per reported executive. Analysis of Adocia's management performance can provide insight into the company performance.
Olivier Soula  CEO
Deputy Chief Executive Officer, Vice President - Research & Development, Director
Gerard Soula  Chairman
Chairman of the Board, Chief Executive Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adocia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Adocia Management Team Effectiveness

The company has return on total asset (ROA) of (0.245) % which means that it has lost $0.245 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.6138) %, meaning that it generated substantial loss on money invested by shareholders. Adocia's management efficiency ratios could be used to measure how well Adocia manages its routine affairs as well as how well it operates its assets and liabilities.

Adocia Workforce Comparison

Adocia is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 854. Adocia retains roughly 110 in number of employees claiming about 13% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.06.

Adocia Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Adocia Price Series Summation is a cross summation of Adocia price series and its benchmark/peer.

Adocia Notable Stakeholders

An Adocia stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Adocia often face trade-offs trying to please all of them. Adocia's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Adocia's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Olivier SoulaDeputy Chief Executive Officer, Vice President - Research & Development, DirectorProfile
Gerard SoulaChairman of the Board, Chief Executive OfficerProfile
Stanislav GlezerMedical DoctorProfile
Valerie DanaguezianChief Financial Officer, Administrative DirectorProfile
Ekaterina SmirnyaginaIndependent DirectorProfile
Laurent ArthaudDirector Representative of Bpifrance InvestissementProfile
Remi SoulaCo-Founder, Director of Bus. Devel. and Intellectual Property and Scientific AdvisorProfile
YouPing ChanScientific DirectorProfile
Geraldine SoulaDirector of Development and Human ResourcesProfile
Sarah GouldDirector of the Preclinical DepartmentProfile
Dominique TakizawaIndependent Member of the BoardProfile
Jose CorreiaHead of the Preclinical and Clinical Department, HSQE Manager and Project ManagerProfile
Valrie DanaguezianCFO DirectorProfile
Martin GaudierHead of Biology DepartmentProfile
David DuracherHead of Pharmaceutical Development and Physical Chemistry DepartmentsProfile
Gregory MeiffrenHead of Biology DepartmentProfile
Grard SoulaChairman, CoFounderProfile
Olivier MBADeputy CoFounderProfile
Grgory MeiffrenHead MangProfile
Olivier MartinezMember of the BoardProfile
Bertrand AlluisHead of Analysis Department and Project ManagerProfile
Richard CharvetHead of Chemistry DepartmentProfile

About Adocia Management Performance

The success or failure of an entity such as Adocia often depends on how effective the management is. Adocia management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adocia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adocia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. ADOCIA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 116 people.
Please note, the presentation of Adocia's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Adocia's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Adocia's management manipulating its earnings.

Adocia Workforce Analysis

Traditionally, organizations such as Adocia use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Adocia within its industry.

Adocia Manpower Efficiency

Return on Adocia Manpower

Revenue Per Employee13.1K
Revenue Per Executive65.6K
Net Loss Per Employee206.9K
Net Loss Per Executive1M
Working Capital Per Employee527.3K
Working Capital Per Executive2.6M

Complementary Tools for Adocia Stock analysis

When running Adocia's price analysis, check to measure Adocia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adocia is operating at the current time. Most of Adocia's value examination focuses on studying past and present price action to predict the probability of Adocia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adocia's price. Additionally, you may evaluate how the addition of Adocia to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world